golgin A8 family member V, pseudogeneGenealiases: []
Q-omics provides the consensus-scored GOLGA8VP profile across patient tissues and cancer cell-line models. GOLGA8VP expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in HNSC. Among the 18 cancer types available for tumor–normal comparison, GOLGA8VP is differentially expressed in 11, with the highest sampling consensus in KIRC. Additionally, GOLGA8VP RNA expression shows 16,415 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight HNSC, KIRC, and UVM as cancer lineages where GOLGA8VP shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for GOLGA8VP — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes GOLGA8VP survival associations across molecular data types. GOLGA8VP RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible GOLGA8VP RNA expression–survival associations across cancer types. High GOLGA8VP expression shows unfavorable associations in KIRC, LGG and ACC, but favorable associations in HNSC, PAAD and CESC. The HNSC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .005). Together, the overview and detailed table identify HNSC as the clearest survival context for GOLGA8VP RNA expression.
This table summarizes GOLGA8VP tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for GOLGA8VP. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. GOLGA8VP shows lower tumor expression in BLCA, THCA, LUAD, COAD and UCEC and higher tumor expression in KIRC. The KIRC box plot shows higher GOLGA8VP RNA expression in tumor versus normal tissue (log2 FC = +0.871, t-test p < 0.001).
This table shows molecular features associated with GOLGA8VP in patient tissues and cancer cell lines. In patient samples, GOLGA8VP shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
